OpenAI and Anthropic have launched competing healthcare AI products—ChatGPT Health and Claude for Healthcare—marking a strategic battle for

The Bristol Myers Squibb-Microsoft collaboration to develop AI-powered lung cancer detection tools signals a fundamental shift in pharmaceutical

Healthcare's most prominent voices are converging on a striking consensus: AI adoption is essential for system survival. From

The AI medical imaging market is transitioning from experimental deployments to an $8.5+ billion industry by 2030. With

The FDA's 2026 AI guidance introduces flexible oversight for medical AI devices, sparking debate about innovation versus patient

The 2026 J.P. Morgan Healthcare Conference revealed a decisive shift in how the industry approaches artificial intelligence. No

Artificial intelligence is transforming oncology through dual capabilities: mapping population-level cancer survival patterns to reveal systemic inequities, and

Major tech companies and academic institutions are converging on a new approach to healthcare AI: tools designed to

Opportunistic AI is transforming routine CT scans into proactive screening tools. Mayo Clinic's new algorithm predicts fall risk

Major healthcare stakeholders are calling for unified federal AI regulation based on risk-tiered frameworks. As the industry moves